The Valley Desk

NCT04641442 · Interventional trial

Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations

Overall registry status Active not recruiting

Phase 2

Conditions NLRC4-GOF, AIFEC (Autoinflammation With Infantile Enterocolitis), XIAP Deficiency, CDC42 Mutations

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov